<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01658397</url>
  </required_header>
  <id_info>
    <org_study_id>2010P001066</org_study_id>
    <nct_id>NCT01658397</nct_id>
  </id_info>
  <brief_title>The Effect of Calorie Deprivation on Adipose Tissue Distribution</brief_title>
  <official_title>The Effect of Calorie Deprivation on Adipose Tissue Distribution</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we will be studying the effects of acute calorie deprivation (a 10-day fast)
      on bone marrow fat, other fat stores and bone parameters. We will be measuring changes in
      bone marrow fat using magnetic resonance spectroscopy and will use MRI to measure
      subcutaneous and visceral fat depots. Our hypothesis is that levels of bone marrow fat will
      increase after an acute fast.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">July 21, 2014</completion_date>
  <primary_completion_date type="Actual">July 21, 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Bone Marrow Adiposity over 10 day fasting period</measure>
    <time_frame>Baseline, After 10 day fasting period</time_frame>
    <description>Bone marrow adiposity will be measured before and after the 10 day fast using magnetic resonance spectroscopy.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Fasting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ten day fast</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Fasting</intervention_name>
    <description>Ten day fast</description>
    <arm_group_label>Fasting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women, ages 21-45 years

          -  101-130% of ideal body weight as defined by the 1983 Metropolitan Life Insurance
             Height and Weight Tables

          -  Normal thyroid function

          -  Regular menses (women)

          -  Normal liver transaminases

        Exclusion Criteria:

          -  Any disease known to affect bone metabolism, including untreated thyroid dysfunction,
             Cushing's syndrome, or renal failure

          -  Any medication known to affect bone metabolism -- including systemic steroids or
             immunosuppressants -- within three months of the study, excluding estrogen and
             progestins. Patients receiving depot medroxyprogesterone (Depo-Provera) will be
             excluded from participating for six months after their last injections.
             Bisphosphonates must have been discontinued for at least one year before participation

          -  Serum potassium &lt;3.0 meq/L

          -  Pregnant and/or breastfeeding (women)

          -  Diabetes mellitus

          -  Active substance abuse, including alcohol

          -  Contraindications to MRI: cardiac pacemaker, metal implants, claustrophobia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pouneh K Fazeli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2012</study_first_submitted>
  <study_first_submitted_qc>August 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2012</study_first_posted>
  <last_update_submitted>February 8, 2017</last_update_submitted>
  <last_update_submitted_qc>February 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Pouneh K. Fazeli, MD</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Healthy subjects</keyword>
  <keyword>Fasting</keyword>
  <keyword>Weight loss</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

